Letters to the Editor

hu128.1, a humanized antibody targeting transferrin receptor 1, blocks erythroleukemia growth in xenograft mouse models

Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA
Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA
Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA
Tumor Microenvironment and Resistance to Treatment Laboratory, IRCM, INSERM U1194, Montpellier, France; Université de Montpellier, Montpellier, France; Institut régional du Cancer de Montpellier (ICM)-Val d’Aurelle, Montpellier
Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, USA; Department of Microbiology, Immunology, and Molecular Genetics. David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; UCLA AIDS Institute, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, USA; The Molecular Biology Institute, UCLA, Los Angeles, CA
Haematologica Early view Dec 12, 2024 https://doi.org/10.3324/haematol.2024.286518